== AUTONOMOUS BIOPHARMA LICENSING MILESTONE ESCROW ==
[1. SYSTEM CLASS & PURPOSE]
Decentralized biopharma milestone escrow on GenLayer anchoring trial payouts ($50M-$500M) directly to verified ClinicalTrials.gov/FDA endpoints without litigation.

[2. TECHNICAL INVARIANTS (JOAQUIN STEWARD REVISION)]
• Strict 5-Point Cross-Verification: Endpoint release strictly requires consensus to verify: (1) registered trial NCT ID match, (2) primary endpoint achieved, (3) strict p-value < 0.05, (4) no FDA safety hold, and (5) categorical CLAIM_ENDPOINT_MET verdict consistent with all 4 fields.
• Safe Inconclusive Non-Payout Path: Any mismatched trial ID, inconsistent fields, or parsing ambiguity falls back to CLAIM_INCONCLUSIVE—preserving milestone principal and claimant bond with zero payout and zero slashing.
• Solvency & Backed Escrow: 100% principal/bonds deposited via @gl.public.write.payable; pull-pattern claimable recovery for failed transfers.

Contract: 0x180b8071498520CCB7954702488A97cDBA801Ba1
